Companies
From start-ups to market leaders, access critical company intelligence on a global scale
Pharmaceutical
Decode the Future of the Pharmaceutical Industry
We have decades of experience in being the trusted, gold standard intelligence provider to leading Pharmaceutical brands, manufacturers, and suppliers, helping them to make faster, more informed decisions.
“As a former CIA analyst, I have a very high bar for being impressed with datasets. You have masterfully combined, in a unified offering, three qualities that are extremely difficult to achieve, even individually: comprehensive coverage, exhaustive sourcing, and an emphasis towards actionability.”
Chief Information Officer, Biotech Company.
Discover our Pharmaceutical Industry Solution
How We Help
Using the collective power of trusted data, expert knowledge and advanced technology, we provide the intelligence you need to decode the future in uncertain times.
Our solutions are designed to help you with key strategic activities.
Market & Competitive Intelligence
Strategic Planning and M&A
Innovation & R&D
Marketing
Business Development
What We Do
We cover the entire spectrum of the pharmaceutical value system – from suppliers, manufacturers and distribution channel, all the way through to insights and trends across the globe.
With in-depth analysis, exclusive news, and highly detailed databases at your fingertips, we give you complete 360° insight into the Pharmaceutical Industry.
Market Data & Insights
- Sales data on over 50,000 pipeline drugs and 85,000 marketed drugs globally, including over 4,100 drugs analyst consensus sales and forecasts entered within 24 hours of release
- Regulatory Milestones Tracker providing interactive search for drug expiries and reviews designations in the US, EU and Japan
- Coverage of ~250,000 Trials (covering rare and niche diseases) – includes observational studies, in addition to interventional and expanded access
- 400,000 clinical Investigators globally, with enrolment data on more than 500 diseases and Trial Sites
- In-depth disease analysis and forecasts on more than 120 disease markets — spanning rare and niche indications and large, well-established markets.
- Expert analysis of disease populations, annualized forecasts of incident and/or prevalent cases (total or diagnosed) with multiple parameters
Investigative News
- Exclusive, hard-hitting, investigative reporting on pipeline drugs as well as intelligence for contract research organizations
- Focus is on uncovering business-critical information that has not been publically divulged and providing nuanced, forward-looking analyses on market-moving healthcare topics
- Reporting is based on talking to Key Opinion Leaders and others with first-hand expertise as well as C-level executives
- Drug Insights helps subscribers conduct due diligence and assess risk on drug candidates ahead of high-impact events such as trial readouts, approvals and market launches
- Outsourcing Insights provides actionable information to help CROs secure new business and gain intel on their competitors
- Content is also available via Real-Time Alerts as well as Daily and Weekly recap emails
Themes
- A single, integrated thematic research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors
- A theme map which monitors the disruptive impact of the top 30 to 40 themes in the sector
- A tool to help senior executives protect their blindside, predict their industry’s future and benchmark their competitors against disruptive threats
Company Intelligence
- Insight on ~250,000 clinical trials from Phase 0 to IV covering all diseases (including rare and niche diseases)
- Track over 50,000 pipeline drugs and 85,000 marketed drugs globally, including country market size, market access and regulatory issues, and key players
- Expert-curated assessments on over 1,100 companies, including Strengths, Weaknesses, Opportunities, and Threats analysis on key players
- Track more than 100,000 companies globally across the pharmaceutical industry value chain
Innovation
- Focus on commercial epidemiology – deeply segmented populations by both new and emerging patient attributes, enabling precise forecasting for niche subpopulations.
- Determine clinical development success rates by Therapy Area, Indication and Molecule Type using Likelihood of Approval and Phase Transition Success Rate tools.
- Identify Sites and Investigators based on their clinical trials experience, ongoing and planned trials, geography and much more
- Benchmark how digital tools are being used to engage patients using Digital Market Intelligence, the industry’s only syndicated digital intelligence offering
Real-time Intelligence
News
- Over 35,000 news alerts every year for an up-to-date view of the latest competitor landscape, including exclusive investigative journalism
- Real-time sentiment analysis of the Top-100 global “Influencers” in the Pharmaceutical Industry
- In-depth coverage of more than 50 international conferences in the US, Europe and Asia.
Deals
- Database of more than 85,000 M&A, strategic alliances and financial transactions for a comprehensive view of investments opportunities
- Real-time monitoring of M&A activity, Strategic Alliances, Capital Raising and Grants, with over 7,000 new deals identified and profiled each year
Analyst Engagement
- Unlimited “Ask an Analyst” functionality with 24-48 hour response time to accelerate decision making
Our Solutions
Intelligence Center
Decode the future by discovering our Pharmaceutical Industry Solution. Request a free no-obligation run-through of our unique and powerful tools.
Reports
We produce hundreds of quantitative and qualitative reports annually. Ranging from strategic reports, industry forecast reports, sector reports, panel reports, insight reports, trend trackers, and country profiles.
Consultancy
Our consulting services provide you with contextualized, real time market insights. Our consultants are highly experienced in helping clients identify new opportunities, minimize risk, gain competitive advantage and improve profitability.